Life Sciences Rebound: What Thermo Fisher's Strong Quarter Really Means The recent quarterly earnings reports from Thermo Fisher Scientific and Danaher have left investors wondering which company is better positioned for future growth in the life sciences industry.
While both companies delivered strong results, a closer look at Thermo Fisher's performance reveals a more nuanced picture. Thermo Fisher's fiscal Q2 2026 numbers are impressive: revenue grew 10% to $11.
99 billion, with GAAP diluted EPS rising 9% to $4. 68 and adjusted EPS growing 13% to $6. 03.